Breast cancer in Egypt, China and Chinese: statistics and beyond

Por Azim, Hamdy A., Ibrahim, Amal S.
Publicado em 2014

Bisphosphonates in the adjuvant treatment of young women with breast cancer: the estrogen rich is a poor candidate!

Por Azim, Hamdy A., Kamal, Nermine S., Malak, Rafaat A.
Publicado em 2013

Analysis of PI3K/mTOR Pathway Biomarkers and Their Prognostic Value in Women with Hormone Receptor–Positive, HER2-Negative Early Breast Cancer()

Por Azim, Hamdy A., Kassem, Loay, Treilleux, Isabelle, Wang, Qing, El Enein, Mona Abu, Anis, Shady E., Bachelot, Thomas
Publicado no Transl Oncol (2016)

A randomized, phase 2 study comparing pemetrexed plus best supportive care versus best supportive care as maintenance therapy after first-line treatment with pemetrexed and cisplat...

Por Mubarak, Nabil, Gaafar, Rabab, Shehata, Samir, Hashem, Tarek, Abigeres, Dani, Azim, Hamdy A, El-Husseiny, Gamal, Al-Husaini, Hamed, Liu, Zhixin
Publicado em 2012

One for the road! A study to assess the efficacy of single low-dose regimen of rasburicase in controlling hyperuricaemia in patients with tumour lysis syndrome due to haematologica...

Por Azim, Hamdy A, Bahr, Sherif Ahmed, Kamal, Nermine Shawky, Koura, Mohamed Adel, Tolba, Rehab, Gad, Heba Abdelmoneem, Morsy, Ahmad, Attia, Hossameldin Mohsen, Iskander, Ibraheem, Hammad, Ahmed, Hemed, Mohammed Farouk, Abdallah, Mohammed Fathy, Sadek, Kareem Ahmed, Taha, Alaa Hamdi
Publicado em 2013